Multimodal Longitudinal and Predictive Modelling to Understand Eating Disorder Development
Key facts
- Who runs it
- King's College London
- Where
- United Kingdom1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 23 people enrolled
- Started
- 15 Nov 2023
- Ended
- 12 Aug 2024
- Type of study
- Observational, 4 groups
- Treatments tested
- MRI scans
- Psychological measures
- Life experiences
- Blood and urine samples
- Mental health symptoms
- Record updated
- 11 December 2024
Who can take part
- Age
- 18 years to 30 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 13 criteriaShow less
Who can take part
- Male and female volunteers, all ethnicities
- Age of 18 to 30
- Sufficient in English (due to validity of neuropsychological measures)
- current DSM-5 binge eating disorder
Who cannot take part
- People who have participated in the STRATIFY, ESTRA or IMAGEN studies previously
- People with brain injuries including stroke, tumours, epilepsy, neurodegenerative or other neurological disorders
- People with type I or type II diabetes
- People who are heavily medicated for serious illness (other than for mental illness)
- People who have a history of anorexia nervosa and have not restored their body weight in the past 6 months
- People who are deaf or have significant hearing problems or a hearing aid that cannot be removed
- People who are blind or have significant vision difficulties (correct near vision of 20/100 or worse in both eyes)
- People who are pregnant or any possibility of being pregnant
- People with restricted mobility, including inability to lie flat for 1.5 hours
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The aim of this observational study is to elucidate the biopsychosocial (including neural, psychological, and social) basis of eating disorders (EDs).
Read full original descriptionShow less
The investigators will use functional and structural neuroimaging, psychological as well as environmental data to identify both shared and distinct behavioural/neural processes across ED diagnoses. The investigators will use advanced statistical methods such as machine learning based models.
The investigators will carry out analysis on the data already collected in the STRATIFY (Brain network based stratification of reinforcement-related disorders, IRAS ID 218030) and IMAGEN studies (Reinforcement-related behaviour in normal brain function and psychopathology, reference PNM/10/11-126), including participants with Anorexia Nervosa (N=60), Bulimia Nervosa (N=52), Binge eating disorder (N=27) and healthy controls. In addition, the investigators will recruit 30 new participants with a binge eating disorder using the original STRATIFY study protocol to enlarge the binge eating disorder group, so that its sample size is comparable to the other groups.
Participants will complete online questionnaires, take an online clinical interview, and undergo a research visit, including brain scans, collection of blood and urine samples, and assessment using a range of cognitive and behavioural measures.
The 4 groups in the trial
- binge eating disorder
Participants with a current binge eating disorder, as assessed by the Eating Disorder Diagnostic Screen (DSM-5 version). These participants have been recruited as part of the STRATIFY study. An additional 30 participants will be recruited in this study to enlarge the sample size, using the same study procedure and assessments in the STRATIFY study.
Treatment: MRI scans, Psychological measures, Life experiences, Blood and urine samples, and Mental health symptoms
- anorexia nervosa
Participants with current anorexia nervosa, as assessed by the Eating Disorder Diagnostic Screen (DSM-5 version).. These participants have been recruited as part of the STRATIFY study. Their data will be used in this study.
Treatment: MRI scans, Psychological measures, Life experiences, Blood and urine samples, and Mental health symptoms
- bulimia nervosa
Participants with current bulimia nervosa, as assessed by the Eating Disorder Diagnostic Screen (DSM-5 version). These participants have been recruited as part of the STRATIFY study. Their data will be used in this study.
Treatment: MRI scans, Psychological measures, Life experiences, Blood and urine samples, and Mental health symptoms
- healthy controls
Healthy controls are selected from the IMAGEN study at the third follow-up (\~age 22 years) who do not exhibit any psychiatric disorder. Their data will be used in this study. IMAGEN and STRATIFY are sister studies that employ matched study protocols.
Treatment: MRI scans, Psychological measures, Life experiences, Blood and urine samples, and Mental health symptoms
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Multimodal Longitudinal and Machine Learning-based Predictive Modelling to Understand the Development of Eating Disorders
- Record updated
- 11 December 2024